The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
The Risk of Lymphoma Development in Autoimmune Diseases: A Meta-analysis
Abstract
BACKGROUND: The risk of development of non-Hodgkin lymphoma (NHL) in autoimmune patients has been investigated in several cohort studies. These studies revealed inconclusive results. To shed some light on this controversy, we conducted a meta-analysis of all available cohort studies linking systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and primary Sjögren syndrome (pSS) to the risk of NHL development. METHODS: We searched the PubMed database (1974 to April 2005) for English-language cohort studies using the key words systemic lupus erythematosus, SLE, rheumatoid arthritis, RA, Sjögren syndrome, or SS; non-Hodgkin lymphoma; and relative risk, RR, standardized incidence rate, or SIR. All cohort studies that used established diagnostic criteria for SLE, RA, and pSS; had histologic confirmation of NHL; and provided standardized incidence rates (SIRs) were included in the meta-analysis. RESULTS: The 20 studies chosen for the analysis included 6 for SLE, 9 for RA, and 5 for pSS. Overall, the meta-analysis suggested extreme heterogeneity among the studies (P < .01; I2 > 70%), high risk of NHL development for pSS (random effects SIR, 18.8; 95% confidence interval [CI], 9.5-37.3); moderate risk for SLE (random effects SIR, 7.4; 95% CI, 3.3-17.0); and lower risk for RA (random effects SIR, 3.9; 95% CI, 2.5-5.9). In RA, the random effects SIRs of NHL with conventional antirheumatic treatment, cytotoxic treatment, and treatment with a biological agent were 2.5 (95% CI, 0.7-9.0), 5.1 (95% CI, 0.9-28.6), and 11.5 (95% CI, 3.7-26.9), respectively. CONCLUSIONS: Rheumatic disease may present a potential risk factor for development of NHL. In this regard, we focused on the underlying pathophysiologic mechanisms related to lymphomagenesis in pSS, SLE, and RA, to justify the varying potential for and background of NHL development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Harris, N., Jaffe, E., Stein, H., Banks, P., Chan, J., Cleary, M., Delsol, G., De Wolf- Peeters, C., Falini, B., & Gatter, K. (1994) · Blood · doi:10.1182/blood.v84.5.1361.1361 · Cited by 6,327
The combination of estimates from different experiments
Cochran, W. G. (1954) · Biometrics · doi:10.2307/3001666 · Cited by 5,380
Investigating and dealing with publication and other biases in meta-analysis
Sterne, J. A. C., Egger, M., & Smith, G. D. (2001) · BMJ · doi:10.1136/bmj.323.7304.101 · Cited by 2,225
Cumulative Meta-Analysis of Therapeutic Trials for Myocardial Infarction
Lau, J., Antman, E. M., Jimenez-Silva, J., Kupelnick, B., Mosteller, F., & Chalmers, T. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207233270406 · Cited by 1,140
Increased Risk of Lymphoma in Sicca Syndrome
KASSAN, S. S., THOMAS, T. L., MOUTSOPOULOS, H. M., HOOVER, R., KIMBERLY, R. P., BUDMAN, D. R., COSTA, J., DECKER, J. L., & CHUSED, T. M. (1978) · Annals of Internal Medicine · doi:10.7326/0003-4819-89-6-888 · Cited by 1,012
International Classification of Diseases, Ninth Revision
National Cancer Institute (2020) · Definitions · doi:10.32388/bd1nux · Cited by 888
Meta‐Analysis Of Controlled Clinical Trials
Whitehead, A. (2002) · doi:10.1002/0470854200 · Cited by 827
Cheema, G. S., Roschke, V., Hilbert, D. M., & Stohl, W. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200106)44:6<1313::aid-art223>3.0.co;2-s · Cited by 802
Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren’s syndrome
Groom, J., Kalled, S. L., Cutler, A. H., Olson, C., Woodcock, S. A., Schneider, P., Tschopp, J., Cachero, T. G., Batten, M., Wheway, J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214121 · Cited by 712
Wolfe, F., & Michaud, K. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20311 · Cited by 644
Incidence of Cancer Among Patients With Rheumatoid Arthritis
Gridley, G., McLaughlin, J. K., Ekbom, A., Klareskog, L., Adami, H.-O., Hacker, D. G., Hoover, R., & Fraumeni, J. F. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.4.307 · Cited by 581
Harris, N. L. (1995) · Current Diagnostic Pathology · doi:10.1016/s0968-6053(00)80051-4 · Cited by 527
Clinical evolution, and morbidity and mortalityof primary Sjögren's syndrome
Skopouli, F. N., Dafni, U., Ioannidis, J. P. A., & Moutsopoulos, H. M. (2000) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(00)80016-5 · Cited by 488
Ioannidis, J. P. A., Vassiliou, V. A., & Moutsopoulos, H. M. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10221 · Cited by 483
Mariette, X. (2002) · Blood · doi:10.1182/blood.v99.11.3909 · Cited by 428
Geborek, P., Bladström, A., Turesson, C., Gulfe, A., Petersson, I. F., Saxne, T., Olsson, H., & Jacobsson, L. T. H. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.030528 · Cited by 427
Rheumatoid arthritis and cancer risk
Mellemkjær, L., Linet, M. S., Gridley, G., Frisch, M., Møller, H., & Olsen, J. H. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00210-9 · Cited by 383
Salloum, E., Cooper, D. L., Howe, G., Lacy, J., Tallini, G., Crouch, J., Schultz, M., & Murren, J. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.6.1943 · Cited by 380
Jacobi, A. M., Odendahl, M., Reiter, K., Bruns, A., Burmester, G. R., Radbruch, A., Valet, G., Lipsky, P. E., & Dörner, T. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10949 · Cited by 361
Risk of malignancy among patients with rheumatic conditions
Thomas, E., Brewster, D. H., Black, R. J., & Macfarlane, G. J. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20001101)88:3<497::aid-ijc27>3.0.co;2-j · Cited by 332
Silman, A. J., Petrie, J., Hazleman, B., & Evans, S. J. (1988) · Annals of the Rheumatic Diseases · doi:10.1136/ard.47.12.988 · Cited by 276
Hansen, A., Odendahl, M., Reiter, K., Jacobi, A. M., Feist, E., Scholze, J., Burmester, G. R., Lipsky, P. E., & Dörner, T. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10445 · Cited by 271
Mellemkjér, L., Andersen, V., Linet, M. S., Gridley, G., Hoover, R., & Olsen, J. H. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400424 · Cited by 231
Increased risk of cancer in patients with systemic lupus erythematosus.
Pettersson, T., Pukkala, E., Teppo, L., & Friman, C. (1992) · Annals of the Rheumatic Diseases · doi:10.1136/ard.51.4.437 · Cited by 194
Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus
Björnådal, L., Löfström, B., Yin, L., Lundberg, I. E., & Ekbom, A. (2002) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740252937568 · Cited by 183
Baecklund, E., Sundström, C., Ekbom, A., Catrina, A. I., Biberfeld, P., Feltelius, N., & Klareskog, L. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11144 · Cited by 180
Malignancy in systemic lupus erythematosus
Abu‐Shakra, M., Gladman, D. D., & Urowitz, M. B. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390625 · Cited by 179
Systemic lupus erythematosus and the risk of malignancy
Cibere, J., Sibley, J., & Haga, M. (2001) · Lupus · doi:10.1191/096120301678646128 · Cited by 173
Malignant Mesothelioma due to Environmental Exposure to Asbestos
Metintaş, S., Metintaş, M., Uçgun, İ., & Öner, Ü. (2002) · CHEST Journal · doi:10.1378/chest.122.6.2224 · Cited by 173
Cancer morbidity in rheumatoid arthritis.
Prior, P., Symmons, D. P., Hawkins, C. F., Scott, D. L., & Brown, R. (1984) · Annals of the Rheumatic Diseases · doi:10.1136/ard.43.2.128 · Cited by 162
Primary Sjogren's syndrome in the North East of England: a long-term follow-up study
Davidson, B., Kelly, C. A., & Griffiths, I. D. (1999) · British journal of rheumatology · doi:10.1093/rheumatology/38.3.245 · Cited by 126
Malone, D. G., Wahl, S. M., Tsokos, M., Cattell, H., Decker, J. L., & Wilder, R. L. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111526 · Cited by 118
Lymphoma in Patients with Rheumatoid Arthritis
Georgescu, L., & Paget, S. A. (1999) · Drug Safety · doi:10.2165/00002018-199920060-00002 · Cited by 83
Zintzaras, E., Chatzoulis, D., Karabatsas, C. H., & Stefanidis, I. (2005) · Journal of Human Genetics · doi:10.1007/s10038-005-0250-z · Cited by 79
Self-citationRisk of malignancy in women with systemic lupus erythematosus.
Dm, S., Manzi, S., Janosky, J. E., Kj, S., Ferri, W. A., Ta, M., & Ramsey‐Goldman, R. (1995) · PubMed · Cited by 71
Zintzaras, E., & Stefanidis, I. (2005) · Journal of Human Genetics · doi:10.1007/s10038-004-0224-6 · Cited by 59
Self-citationValidity of rheumatoid arthritis diagnoses listed in the saskatchewan hospital separations database
Tennis, P. S. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90048-6 · Cited by 49
Cited by
Armitage, J. O., Gascoyne, R. D., Lunning, M. A., & Cavalli, F. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32407-2 · Cited by 1,176
Mariette, X., & Criswell, L. A. (2018) · New England Journal of Medicine · doi:10.1056/nejmcp1702514 · Cited by 947
Epidemiology of primary Sjögren’s syndrome: a systematic review and meta-analysis
Qin, B., Wang, J., Yang, Z., Yang, M., Ma, N., Huang, F., & Zhong, R. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205375 · Cited by 882
Ekström Smedby, K., Vajdic, C. M., Falster, M., Engels, E. A., Martínez-Maza, O., Turner, J., Hjalgrim, H., Vineis, P., Seniori Costantini, A., Bracci, P. M., et al. (2008) · Blood · doi:10.1182/blood-2007-10-119974 · Cited by 624
Dougan, M., & Dranoff, G. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132544 · Cited by 607
Metadata
- Authors
- Zintzaras, E.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2005-11-14
- Volume
- 165
- Issue
- 20
- Pages
- 2337
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2024308747
- Cited by
- 771
- References
- 40
- FWCI
- 16.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.